Loading…
Synthesis, antimycobacterial activity evaluation, and QSAR studies of chalcone derivatives
Twenty-five chalcones were synthesized, and their activity was evaluated by luciferase reporter phage (LRP) assay, and quantitative structure–activity relationship (QSAR) was developed. In order to develop relatively small molecules as antimycobacterial agents, twenty-five chalcones were synthesized...
Saved in:
Published in: | Bioorganic & medicinal chemistry letters 2007-03, Vol.17 (6), p.1695-1700 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Twenty-five chalcones were synthesized, and their activity was evaluated by luciferase reporter phage (LRP) assay, and quantitative structure–activity relationship (QSAR) was developed.
In order to develop relatively small molecules as antimycobacterial agents, twenty-five chalcones were synthesized, their activity was evaluated, and quantitative structure–activity relationship (QSAR) was developed. The synthesis was based on the Claisen-Schimdt scheme and the resultant compounds were tested for antitubercular activity by luciferase reporter phage (LRP) assay. Compound
C
24
was found to be the most active (∼99%) in this series based on the percentage reduction in Relative Light Units at both 50 and 100
μg/ml levels, followed by compound
C
21
. Four compounds at the 50
μg/ml and eight compounds at the 100
μg/ml showed activity above 90% level. QSAR model was developed between activity and spatial, topological, and ADME descriptors for the 50
μg/ml data. The statistical measures such as
r,
r
2,
q
2, and
F values obtained for the training set were in acceptable range and hence this relationship was used for the test set. The predictive ability of the model is satisfactory (
q
2
=
0.56) and it can be used for designing similar group of compounds. |
---|---|
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2006.12.112 |